Blood Pressure, Depression
Conditions
Brief summary
A large body of medical research has shown that sleep deprivation adversely affects outcomes ranging from cognitive function to pain sensitivity and cardiovascular function. Much of this evidence comes from sleep labs in the developed world, where sleep can be carefully manipulated, and short-run physiological and cognitive outcomes precisely measured. In contrast, there is much less knowledge about how sleep deprivation affects the health of individuals in the developing world, coming from a lack of studies outside the lab and over longer periods. This project aims to fill this gap. The investigators will implement a randomized controlled trial (RCT) with 450 low-income adults in Chennai, India, providing the first objective measurement of sleep in a developing country. The investigators will also evaluate scalable interventions to improve the sleep of poor adults, such as providing home sleep-aid devices and a comfortable space for a 30-minute afternoon nap at the participants' work site. Finally, the study aims to assess the impact of improved sleep on health, with a primary focus on cardiovascular health and cognitive outcomes.
Interventions
After a baseline period, participants in this condition will be provided with the opportunity to nap in a quiet comfortable nap cabin in the study office for 30 minutes each afternoon on all work days.
After a baseline period, participants in this condition will be provided with a set of home sleep aids (e.g. earplugs, eyeshades, a basic mattress, sheets, and pillow, etc) to take home with them if they wish. These sleep aids and their proper use are described to the participants and they are encouraged to use them if they find them helpful.
After a baseline period, participants in this condition will be provided with a small payment for each additional minute of sleep over their mean nighttime sleep in the baseline period.
Sponsors
Study design
Eligibility
Inclusion criteria
* Unemployed and underemployed adult men and women of working age (see previous age limit) who have worked less than 5 days per week over the last month and earned less than Rs. 700 per day over that same period. * Participants must live in Government board house or in a house with some kind of roof that protect the sleep aids from rain, such as a concrete or a metal or a Tarpaulin, ... roof. * Have limited experience with typing, and limited knowledge of English. * Participants need to speak Tamil, the local language, to be able to write numbers and to be able to commit easily to the office.
Exclusion criteria
* Participants who cannot commit to come to the office for the duration of the whole study. * Participants who own more than three of the sleep aids that we provide in our sleep kit. * Participants who have previously participated in the sleep study. * Participants who have children younger than three years old.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Sleep Per 24 Hours | Actigraphs are worn consistently throughout the study. The sleep per 24 hour period outcome is then measured every day through study completion, which is 28 business days (as well as intervening holidays and Sundays) for each participant. | Sleep is measured via actigraph. 24 hour sleep is the sum of night sleep and nap sleep. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Depression | Depression is measured once in the baseline on the first day of the study and a second time in the endline, which takes place on the last day of the study, 28 business days after the first day in the study for the participant. | The investigators measure depression using a scale defined by the Patient Health Questionnaire (PHQ), which is a self-administered version of the PRIME-MD diagnostic instrument for common mental disorders. Each criteria is scored from 0 (not at all, a better outcome) to 3 (nearly every day, a worse outcome). Scores on each question are summed, defining depression severity. The outcome measure was the total summed score captured at endline (day 28). The outcome is thus measured on a scale from 0 to 27, where 0 represents the best outcome and 27 represents the worst outcome. |
| Number of Days of Illness in Past Week | Illness is measured once in the baseline on the first day of the study and a second time in the endline, which takes place on the last day of the study, 28 business days after the first day in the study for the participant. | Illness is measured as the number of days of illness (e.g. cough, fever) in the past week. The outcome measure is the number of days of illness in the past week self-reported at endline (day 28). |
| Inhibitory Control | From date of entering the study through completion of the study after 28 business days, the inhibitory control is measured once every two business days (which of the two is randomly assigned). | Hearts and flowers test -- The outcome used is the payment for the task which is a linear combination of the participant's accuracy (percent correct) and reaction time (measured in milliseconds). Specifically, the payment for this task is determined by the formula: 1.5 \* ((percent correct - 0.84) / 0.2 - (reaction time - 526.5) / 95.2) + 15. The outcome measure is the average of the measures collected for each individual after the baseline period (starting on day 9). |
| Memory | From date of entering the study through completion of the study after 28 business days, memory is measured once every two business days (which of the two is randomly assigned). | Corsi block span - The investigators' measure of memory is the longest correct sequence of blocks lighting in a random order that a participant can reproduce. The range is from a minimum of 0 (worst performance) to a maximum of 9 (best performance). The outcome reported for this task is the participant's payment from the task, which is computed based on their longest span as well as baseline data: 2.29\*(maximum span - 5.3) / 1.17 + 13. The outcome measure is the average of the measures collected for each individual after the baseline period (starting on day 9). |
| Attention | From date of entering the study through completion of the study after 28 business days, attention is measured once every two business days (which of the two is randomly assigned). | Psychomotor Vigilance Task (PVT) - The outcome is payment for the task which was a predetermined linear combination of the inverse reaction time, the number of false positives (response when they participant should not have responded), and the number of lapses (reaction time \>500ms). Specifically, the payment was determined by the formula: (inverse reaction time - 3.5)/0.42 - (0.5\*(number of false positives-4.7)/6.14) - (0.5\*(number of lapses-1.3)/2.58) + 15. Higher payments indicate better performance. Although the theoretical minimum possible score is negative infinity, in practice, the minimum possible payment was censored at zero. The maximum theoretical payment is undefined. The payment reflects overall performance. The outcome measure is the average of the measures collected for each individual after the baseline period (starting on day 9). |
| Blood Pressure | From date of entering the study through completion of the study after 28 business days, blood pressure is measured once every block of three business days. The date of measurement is randomized within each block between the first, second, and third day. | Systolic, Diastolic. The outcome measurements reported here are those captured after the baseline period (starting on day 9). Each measure is first winsorized at the 5% level and standardized using control group data, to mean 0 and standard deviation 1. The measure is then multiplied by -1 such that higher values represent improvements in health. In order to analyze these outcomes jointly, this measure is next averaged to obtain an overall measure and standardized again. The mean is taken across all participant observations within a group regardless of the time after the baseline period. There are no clinically relevant values and the measure has no max and min. |
| Physical Fitness | Physical fitness is measured only once in the endline, which takes place on the last day of the study, 28 business days after the first day in the study for the participant. | The outcome measure is the number of kilometers participants can cover on a stationary exercise cycle over a period of 30 minutes, as reported on the display of the exercise cycle.The cycle was set to the same level of resistance for all participants. |
| Activities of Daily Living | Activities of daily living are measured once in the baseline on the first day of the study and a second time in the endline, which takes place on the last day of the study, 28 business days after the first day in the study for the participant. | The investigators use survey questions taken from the commonly used SF-36 Health survey asking participants how much their health has limited them in a certain number of activities. The possible answers range from they did not limit you at all (0, the best outcome) to limited you a lot (3, the worst outcome). The final scale, which is the sum of the answers, goes from 0 for people who are not limited at all in their daily life by their health to 36 for people who are substantially limited in their daily life by their health. The outcome measure is the 0-36 scale captured at endline (day 28). |
| Subjective Well-being | Subjective well-being is measured once in the baseline on the first day of the study and a second time in the endline, which takes place on the last day of the study, 28 business days after the first day in the study for the participant. | The measure of the outcome is based on two survey questions taken from Gallup Survey. In the first question, participants are asked to state a number from 0 to 10, with 0 being a feeling that the participant has the worst possible life while 10 is a feeling that the participant has the best possible life. In the second question, participants are asked to state a number from 0 to 10, with 0 being a feeling that the participant is dissatisfied with life as a whole and 10 being a feeling that the participant is satisfied with life as a whole. The final scale, generated by summing the individual items, is then from 0 for highly dissatisfied people to 20 for highly satisfied people. The outcome measure is the 0-20 scale captured at endline (day 28). |
| Happiness | Happiness is measured in the baseline on the first day of the study, randomly once every block of three business days during the study, and a last time in the endline, on the last day of the study, 28 business days after the participant's first day. | The investigators use a question adapted from a Gallup poll and from the SF-36 survey by RAND that ask participants to rate their happiness on the present day from Not at all happy (0, the worst outcome) to very happy (4, the best outcome). The outcome measure is the average of the measures collected for each individual after the baseline period (starting on day 9) |
| Self-reported Pain | Pain is measured once in the baseline on the first day of the study and a second time in the endline, which takes place on the last day of the study, 28 days after the first day in the study for the participant. | The investigators use a simple scale of 0 (no pain) to 10 (the worst pain imaginable) for the participant to rate their pain intensity. The outcome measure was the self-reported pain intensity captured at endline (day 28). |
Countries
India
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Control No changes to normal sleep habits. | 77 |
| Naps Only After a baseline period, participants in this condition will be provided with the opportunity to nap in a quiet comfortable nap cabin in the study office for 30 minutes each afternoon on all work days.
Naps: After a baseline period, participants in this condition will be provided with the opportunity to nap in a quiet comfortable nap cabin in the study office for 30 minutes each afternoon on all work days. | 75 |
| Home Sleep Aids Only After a baseline period, participants in this condition will be provided with a set of home sleep aids (e.g. earplugs, eyeshades, a basic mattress, sheets, and pillow, etc) to take home with them if they wish. These sleep aids and their proper use are described to the participants and they are encouraged to use them if they find them helpful.
Home sleep aids: After a baseline period, participants in this condition will be provided with a set of home sleep aids (e.g. earplugs, eyeshades, a basic mattress, sheets, and pillow, etc) to take home with them if they wish. These sleep aids and their proper use are described to the participants and they are encouraged to use them if they find them helpful. | 75 |
| Home Sleep Aids + Sleep Incentives After a baseline period, participants in this condition will be provided with a set of home sleep aids (e.g. earplugs, eyeshades, a basic mattress, sheets, and pillow, etc) to take home with them if they wish. These sleep aids and their proper use are described to the participants and they are encouraged to use them if they find them helpful. In addition, they will be given a small payment for each additional minute of sleep over their mean nighttime sleep in the baseline period.
Home sleep aids: After a baseline period, participants in this condition will be provided with a set of home sleep aids (e.g. earplugs, eyeshades, a basic mattress, sheets, and pillow, etc) to take home with them if they wish. These sleep aids and their proper use are described to the participants and they are encouraged to use them if they find them helpful.
Sleep incentives: After a baseline period, participants in this condition will be provided with a small payment for each additional minute of sleep over their mean nighttime sleep in the baseline period. | 74 |
| Naps + Home Sleep Aids After a baseline period, participants in this condition will be provided with: 1) the opportunity to nap in a quiet comfortable nap cabin in the study office for 30 minutes each afternoon on all work days, 2) a set of home sleep aids (e.g. earplugs, eyeshades, a basic mattress, sheets, and pillow, etc) to take home with them if they wish. These sleep aids and their proper use are described to the participants and they are encouraged to use them if they find them helpful.
Naps: After a baseline period, participants in this condition will be provided with the opportunity to nap in a quiet comfortable nap cabin in the study office for 30 minutes each afternoon on all work days.
Home sleep aids: After a baseline period, participants in this condition will be provided with a set of home sleep aids (e.g. earplugs, eyeshades, a basic mattress, sheets, and pillow, etc) to take home with them if they wish. These sleep aids and their proper use are described to the participants and they are encouraged to use them if they find them helpful. | 75 |
| Naps + Home Sleep Aids + Sleep Incentives After a baseline period, participants in this condition will be provided with: 1) the opportunity to nap in a quiet comfortable nap cabin in the study office for 30 minutes each afternoon on all work days, 2) a set of home sleep aids (e.g. earplugs, eyeshades, a basic mattress, sheets, and pillow, etc) to take home with them if they wish, and 3) a small payment for each additional minute of sleep over their mean nighttime sleep in the baseline period. The sleep aids and their proper use are described to the participants and they are encouraged to use them if they find them helpful.
Naps: After a baseline period, participants in this condition will be provided with the opportunity to nap in a quiet comfortable nap cabin in the study office for 30 minutes each afternoon on all work days.
Home sleep aids: After a baseline period, participants in this condition will be provided with a set of home sleep aids (e.g. earplugs, eyeshades, a basic mattress, sheets, and pillow, etc) to take home with them if they wish. These sleep aids and their proper use are described to the participants and they are encouraged to use them if they find them helpful.
Sleep incentives: After a baseline period, participants in this condition will be provided with a small payment for each additional minute of sleep over their mean nighttime sleep in the baseline period. | 76 |
| Total | 452 |
Baseline characteristics
| Characteristic | Control | Naps Only | Home Sleep Aids Only | Home Sleep Aids + Sleep Incentives | Naps + Home Sleep Aids | Naps + Home Sleep Aids + Sleep Incentives | Total |
|---|---|---|---|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical Between 18 and 65 years | 77 Participants | 75 Participants | 75 Participants | 74 Participants | 75 Participants | 76 Participants | 452 Participants |
| Age, Continuous | 35.91 Years STANDARD_DEVIATION 0.86 | 35.77 Years STANDARD_DEVIATION 0.89 | 35.04 Years STANDARD_DEVIATION 0.8 | 33.82 Years STANDARD_DEVIATION 0.74 | 35.52 Years STANDARD_DEVIATION 0.85 | 33.62 Years STANDARD_DEVIATION 0.83 | 34.95 Years STANDARD_DEVIATION 2.03 |
| Hours of sleep/24 hours | 5.509 Hours of sleep/24 hours STANDARD_DEVIATION 1.261 | 5.584 Hours of sleep/24 hours STANDARD_DEVIATION 1.204 | 5.588 Hours of sleep/24 hours STANDARD_DEVIATION 1.186 | 5.640 Hours of sleep/24 hours STANDARD_DEVIATION 1.118 | 5.542 Hours of sleep/24 hours STANDARD_DEVIATION 1.291 | 5.567 Hours of sleep/24 hours STANDARD_DEVIATION 1.144 | 5.581 Hours of sleep/24 hours STANDARD_DEVIATION 1.197 |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 77 Participants | 75 Participants | 75 Participants | 74 Participants | 75 Participants | 76 Participants | 452 Participants |
| Race (NIH/OMB) Black or African American | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) More than one race | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) White | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Region of Enrollment India | 77 participants | 75 participants | 75 participants | 74 participants | 75 participants | 76 participants | 452 participants |
| Sex: Female, Male Female | 52 Participants | 48 Participants | 48 Participants | 47 Participants | 48 Participants | 56 Participants | 299 Participants |
| Sex: Female, Male Male | 25 Participants | 27 Participants | 27 Participants | 27 Participants | 27 Participants | 20 Participants | 153 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk | EG003 affected / at risk | EG004 affected / at risk | EG005 affected / at risk |
|---|---|---|---|---|---|---|
| deaths Total, all-cause mortality | 0 / 77 | 0 / 75 | 0 / 75 | 0 / 74 | 0 / 75 | 0 / 76 |
| other Total, other adverse events | 0 / 77 | 0 / 75 | 0 / 75 | 0 / 74 | 0 / 75 | 0 / 76 |
| serious Total, serious adverse events | 0 / 77 | 0 / 75 | 0 / 75 | 0 / 74 | 0 / 75 | 0 / 76 |
Outcome results
Sleep Per 24 Hours
Sleep is measured via actigraph. 24 hour sleep is the sum of night sleep and nap sleep.
Time frame: Actigraphs are worn consistently throughout the study. The sleep per 24 hour period outcome is then measured every day through study completion, which is 28 business days (as well as intervening holidays and Sundays) for each participant.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control | Sleep Per 24 Hours | 5.61 Hours of sleep/24 hours | Standard Deviation 1.2 |
| Naps Only | Sleep Per 24 Hours | 5.81 Hours of sleep/24 hours | Standard Deviation 1.259 |
| Home Sleep Aids Only | Sleep Per 24 Hours | 5.99 Hours of sleep/24 hours | Standard Deviation 1.239 |
| Home Sleep Aids + Sleep Incentives | Sleep Per 24 Hours | 6.23 Hours of sleep/24 hours | Standard Deviation 1.312 |
| Naps + Home Sleep Aids | Sleep Per 24 Hours | 6.08 Hours of sleep/24 hours | Standard Deviation 1.305 |
| Naps + Home Sleep Aids + Sleep Incentives | Sleep Per 24 Hours | 6.35 Hours of sleep/24 hours | Standard Deviation 1.208 |
Activities of Daily Living
The investigators use survey questions taken from the commonly used SF-36 Health survey asking participants how much their health has limited them in a certain number of activities. The possible answers range from they did not limit you at all (0, the best outcome) to limited you a lot (3, the worst outcome). The final scale, which is the sum of the answers, goes from 0 for people who are not limited at all in their daily life by their health to 36 for people who are substantially limited in their daily life by their health. The outcome measure is the 0-36 scale captured at endline (day 28).
Time frame: Activities of daily living are measured once in the baseline on the first day of the study and a second time in the endline, which takes place on the last day of the study, 28 business days after the first day in the study for the participant.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control | Activities of Daily Living | 8.961 Score on a scale | Standard Deviation 7.378 |
| Naps Only | Activities of Daily Living | 7.52 Score on a scale | Standard Deviation 6.795 |
| Home Sleep Aids Only | Activities of Daily Living | 7.8 Score on a scale | Standard Deviation 7.674 |
| Home Sleep Aids + Sleep Incentives | Activities of Daily Living | 7.486 Score on a scale | Standard Deviation 7.323 |
| Naps + Home Sleep Aids | Activities of Daily Living | 7.36 Score on a scale | Standard Deviation 6.06 |
| Naps + Home Sleep Aids + Sleep Incentives | Activities of Daily Living | 7.553 Score on a scale | Standard Deviation 7.43 |
Attention
Psychomotor Vigilance Task (PVT) - The outcome is payment for the task which was a predetermined linear combination of the inverse reaction time, the number of false positives (response when they participant should not have responded), and the number of lapses (reaction time \>500ms). Specifically, the payment was determined by the formula: (inverse reaction time - 3.5)/0.42 - (0.5\*(number of false positives-4.7)/6.14) - (0.5\*(number of lapses-1.3)/2.58) + 15. Higher payments indicate better performance. Although the theoretical minimum possible score is negative infinity, in practice, the minimum possible payment was censored at zero. The maximum theoretical payment is undefined. The payment reflects overall performance. The outcome measure is the average of the measures collected for each individual after the baseline period (starting on day 9).
Time frame: From date of entering the study through completion of the study after 28 business days, attention is measured once every two business days (which of the two is randomly assigned).
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control | Attention | 13.001 Indian Rupees | Standard Deviation 1.568 |
| Naps Only | Attention | 13.338 Indian Rupees | Standard Deviation 1.418 |
| Home Sleep Aids Only | Attention | 13.024 Indian Rupees | Standard Deviation 1.569 |
| Home Sleep Aids + Sleep Incentives | Attention | 13.005 Indian Rupees | Standard Deviation 1.518 |
| Naps + Home Sleep Aids | Attention | 13.174 Indian Rupees | Standard Deviation 1.589 |
| Naps + Home Sleep Aids + Sleep Incentives | Attention | 13.150 Indian Rupees | Standard Deviation 1.495 |
Blood Pressure
Systolic, Diastolic. The outcome measurements reported here are those captured after the baseline period (starting on day 9). Each measure is first winsorized at the 5% level and standardized using control group data, to mean 0 and standard deviation 1. The measure is then multiplied by -1 such that higher values represent improvements in health. In order to analyze these outcomes jointly, this measure is next averaged to obtain an overall measure and standardized again. The mean is taken across all participant observations within a group regardless of the time after the baseline period. There are no clinically relevant values and the measure has no max and min.
Time frame: From date of entering the study through completion of the study after 28 business days, blood pressure is measured once every block of three business days. The date of measurement is randomized within each block between the first, second, and third day.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control | Blood Pressure | 0.000 Blood pressure index | Standard Deviation 1 |
| Naps Only | Blood Pressure | 0.135 Blood pressure index | Standard Deviation 0.891 |
| Home Sleep Aids Only | Blood Pressure | 0.110 Blood pressure index | Standard Deviation 0.981 |
| Home Sleep Aids + Sleep Incentives | Blood Pressure | 0.071 Blood pressure index | Standard Deviation 0.95 |
| Naps + Home Sleep Aids | Blood Pressure | 0.027 Blood pressure index | Standard Deviation 1.025 |
| Naps + Home Sleep Aids + Sleep Incentives | Blood Pressure | 0.178 Blood pressure index | Standard Deviation 0.902 |
Depression
The investigators measure depression using a scale defined by the Patient Health Questionnaire (PHQ), which is a self-administered version of the PRIME-MD diagnostic instrument for common mental disorders. Each criteria is scored from 0 (not at all, a better outcome) to 3 (nearly every day, a worse outcome). Scores on each question are summed, defining depression severity. The outcome measure was the total summed score captured at endline (day 28). The outcome is thus measured on a scale from 0 to 27, where 0 represents the best outcome and 27 represents the worst outcome.
Time frame: Depression is measured once in the baseline on the first day of the study and a second time in the endline, which takes place on the last day of the study, 28 business days after the first day in the study for the participant.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control | Depression | 5.208 Score on 0-27 scale | Standard Deviation 5.131 |
| Naps Only | Depression | 4.676 Score on 0-27 scale | Standard Deviation 4.726 |
| Home Sleep Aids Only | Depression | 5.851 Score on 0-27 scale | Standard Deviation 5.529 |
| Home Sleep Aids + Sleep Incentives | Depression | 5.095 Score on 0-27 scale | Standard Deviation 5.113 |
| Naps + Home Sleep Aids | Depression | 5.608 Score on 0-27 scale | Standard Deviation 5.226 |
| Naps + Home Sleep Aids + Sleep Incentives | Depression | 5.147 Score on 0-27 scale | Standard Deviation 5.339 |
Happiness
The investigators use a question adapted from a Gallup poll and from the SF-36 survey by RAND that ask participants to rate their happiness on the present day from Not at all happy (0, the worst outcome) to very happy (4, the best outcome). The outcome measure is the average of the measures collected for each individual after the baseline period (starting on day 9)
Time frame: Happiness is measured in the baseline on the first day of the study, randomly once every block of three business days during the study, and a last time in the endline, on the last day of the study, 28 business days after the participant's first day.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control | Happiness | 2.455 Score on a scale | Standard Deviation 0.758 |
| Naps Only | Happiness | 2.517 Score on a scale | Standard Deviation 0.768 |
| Home Sleep Aids Only | Happiness | 2.421 Score on a scale | Standard Deviation 0.754 |
| Home Sleep Aids + Sleep Incentives | Happiness | 2.440 Score on a scale | Standard Deviation 0.725 |
| Naps + Home Sleep Aids | Happiness | 2.580 Score on a scale | Standard Deviation 0.676 |
| Naps + Home Sleep Aids + Sleep Incentives | Happiness | 2.502 Score on a scale | Standard Deviation 0.783 |
Inhibitory Control
Hearts and flowers test -- The outcome used is the payment for the task which is a linear combination of the participant's accuracy (percent correct) and reaction time (measured in milliseconds). Specifically, the payment for this task is determined by the formula: 1.5 \* ((percent correct - 0.84) / 0.2 - (reaction time - 526.5) / 95.2) + 15. The outcome measure is the average of the measures collected for each individual after the baseline period (starting on day 9).
Time frame: From date of entering the study through completion of the study after 28 business days, the inhibitory control is measured once every two business days (which of the two is randomly assigned).
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control | Inhibitory Control | 14.982 Indian Rupees | Standard Deviation 1.371 |
| Naps Only | Inhibitory Control | 14.957 Indian Rupees | Standard Deviation 1.328 |
| Home Sleep Aids Only | Inhibitory Control | 15.078 Indian Rupees | Standard Deviation 1.213 |
| Home Sleep Aids + Sleep Incentives | Inhibitory Control | 14.982 Indian Rupees | Standard Deviation 1.086 |
| Naps + Home Sleep Aids | Inhibitory Control | 15.039 Indian Rupees | Standard Deviation 1.338 |
| Naps + Home Sleep Aids + Sleep Incentives | Inhibitory Control | 15.103 Indian Rupees | Standard Deviation 1.301 |
Memory
Corsi block span - The investigators' measure of memory is the longest correct sequence of blocks lighting in a random order that a participant can reproduce. The range is from a minimum of 0 (worst performance) to a maximum of 9 (best performance). The outcome reported for this task is the participant's payment from the task, which is computed based on their longest span as well as baseline data: 2.29\*(maximum span - 5.3) / 1.17 + 13. The outcome measure is the average of the measures collected for each individual after the baseline period (starting on day 9).
Time frame: From date of entering the study through completion of the study after 28 business days, memory is measured once every two business days (which of the two is randomly assigned).
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control | Memory | 14.643 Indian Rupees | Standard Deviation 2.675 |
| Naps Only | Memory | 14.834 Indian Rupees | Standard Deviation 2.519 |
| Home Sleep Aids Only | Memory | 14.931 Indian Rupees | Standard Deviation 2.499 |
| Home Sleep Aids + Sleep Incentives | Memory | 14.483 Indian Rupees | Standard Deviation 2.384 |
| Naps + Home Sleep Aids | Memory | 14.609 Indian Rupees | Standard Deviation 2.796 |
| Naps + Home Sleep Aids + Sleep Incentives | Memory | 14.645 Indian Rupees | Standard Deviation 2.608 |
Number of Days of Illness in Past Week
Illness is measured as the number of days of illness (e.g. cough, fever) in the past week. The outcome measure is the number of days of illness in the past week self-reported at endline (day 28).
Time frame: Illness is measured once in the baseline on the first day of the study and a second time in the endline, which takes place on the last day of the study, 28 business days after the first day in the study for the participant.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control | Number of Days of Illness in Past Week | 2.08 Days of illness in the past week | Standard Deviation 2.448 |
| Naps Only | Number of Days of Illness in Past Week | 1.732 Days of illness in the past week | Standard Deviation 1.836 |
| Home Sleep Aids Only | Number of Days of Illness in Past Week | 1.973 Days of illness in the past week | Standard Deviation 2.56 |
| Home Sleep Aids + Sleep Incentives | Number of Days of Illness in Past Week | 2.041 Days of illness in the past week | Standard Deviation 2.556 |
| Naps + Home Sleep Aids | Number of Days of Illness in Past Week | 2.351 Days of illness in the past week | Standard Deviation 2.55 |
| Naps + Home Sleep Aids + Sleep Incentives | Number of Days of Illness in Past Week | 1.853 Days of illness in the past week | Standard Deviation 2.228 |
Physical Fitness
The outcome measure is the number of kilometers participants can cover on a stationary exercise cycle over a period of 30 minutes, as reported on the display of the exercise cycle.The cycle was set to the same level of resistance for all participants.
Time frame: Physical fitness is measured only once in the endline, which takes place on the last day of the study, 28 business days after the first day in the study for the participant.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control | Physical Fitness | 3.717 km | Standard Deviation 1.626 |
| Naps Only | Physical Fitness | 3.857 km | Standard Deviation 1.357 |
| Home Sleep Aids Only | Physical Fitness | 3.941 km | Standard Deviation 1.924 |
| Home Sleep Aids + Sleep Incentives | Physical Fitness | 3.934 km | Standard Deviation 2.157 |
| Naps + Home Sleep Aids | Physical Fitness | 3.697 km | Standard Deviation 1.446 |
| Naps + Home Sleep Aids + Sleep Incentives | Physical Fitness | 3.571 km | Standard Deviation 1.384 |
Self-reported Pain
The investigators use a simple scale of 0 (no pain) to 10 (the worst pain imaginable) for the participant to rate their pain intensity. The outcome measure was the self-reported pain intensity captured at endline (day 28).
Time frame: Pain is measured once in the baseline on the first day of the study and a second time in the endline, which takes place on the last day of the study, 28 days after the first day in the study for the participant.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control | Self-reported Pain | 2.740 Score on a scale | Standard Deviation 2.721 |
| Naps Only | Self-reported Pain | 3.070 Score on a scale | Standard Deviation 2.276 |
| Home Sleep Aids Only | Self-reported Pain | 2.095 Score on a scale | Standard Deviation 2.517 |
| Home Sleep Aids + Sleep Incentives | Self-reported Pain | 2.838 Score on a scale | Standard Deviation 2.477 |
| Naps + Home Sleep Aids | Self-reported Pain | 2.608 Score on a scale | Standard Deviation 2.52 |
| Naps + Home Sleep Aids + Sleep Incentives | Self-reported Pain | 2.800 Score on a scale | Standard Deviation 2.568 |
Subjective Well-being
The measure of the outcome is based on two survey questions taken from Gallup Survey. In the first question, participants are asked to state a number from 0 to 10, with 0 being a feeling that the participant has the worst possible life while 10 is a feeling that the participant has the best possible life. In the second question, participants are asked to state a number from 0 to 10, with 0 being a feeling that the participant is dissatisfied with life as a whole and 10 being a feeling that the participant is satisfied with life as a whole. The final scale, generated by summing the individual items, is then from 0 for highly dissatisfied people to 20 for highly satisfied people. The outcome measure is the 0-20 scale captured at endline (day 28).
Time frame: Subjective well-being is measured once in the baseline on the first day of the study and a second time in the endline, which takes place on the last day of the study, 28 business days after the first day in the study for the participant.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control | Subjective Well-being | 11.554 Score on a scale | Standard Deviation 4.78 |
| Naps Only | Subjective Well-being | 12.521 Score on a scale | Standard Deviation 4.004 |
| Home Sleep Aids Only | Subjective Well-being | 11.906 Score on a scale | Standard Deviation 4.588 |
| Home Sleep Aids + Sleep Incentives | Subjective Well-being | 11.919 Score on a scale | Standard Deviation 4.336 |
| Naps + Home Sleep Aids | Subjective Well-being | 12.757 Score on a scale | Standard Deviation 4.132 |
| Naps + Home Sleep Aids + Sleep Incentives | Subjective Well-being | 12.199 Score on a scale | Standard Deviation 4.489 |